Last Posted: Sep 22, 2017
- The big question: Will cancer immune therapy work for me?
Stat News Associated Press, Sep 20, 2017
- Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype.
Lowery Maeve A et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Jul
- Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy.
Rosenbaum Lisa et al. The New England journal of medicine 2017 Sep
- Chimeric Antigen Receptor (CAR) T-Cell Therapy- Patient Page
JM Pagel et al, JAMA Oncology, Sep 7, 2017
- Targeting Immune Checkpoints in Cancer Therapy
SL Topalian, JAMA, Sep 8, 2017
- Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
Albaba Hamzeh et al. PharmacoEconomics 2017 Aug
- FDA Approves First CAR-T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia
NIH Director's blog, September, 2p017
- CAR T Cells: Engineering Patients Immune Cells to Treat Their Cancers
August 31, 2017
- Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.
Reck Martin et al. The New England journal of medicine 2017 Aug (9) 849-861
- Gut bacteria associated with cancer immunotherapy response in melanoma
Science Mag, August 20, 2017
- NCI study identifies essential genes for cancer immunotherapy
NCI, August 7, 2017
- Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.
Sonneveld Pieter et al. Blood 2016 Jun 127(24) 2955-62
- Identification of essential genes for cancer immunotherapy
SJ Patel et al, Nature August 7, 2017
- Genetic biomarker for cancer immunotherapy
S Goswami et al, Science, July 28, 2017
- Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.
Johanns Tanner M et al. Cancer journal (Sudbury, Mass.) 23(2) 125-130
- Longitudinal analysis of treatment-induced genomic alterations in gliomas.
Erson-Omay E Zeynep et al. Genome medicine 2017 Feb 9(1) 12